Noel Dela Paz

Noel Dela Paz has a diverse work experience in the pharmaceutical industry. Noel is currently working as the Senior Director of New Product Planning at Celldex Therapeutics since July 2022. Prior to this, from November 2020 to June 2022, they served as the Director of Global Strategic Marketing at Acceleron Pharma, a subsidiary of Merck & Co., Inc.

From February 2018 to February 2020, Noel was the Director of Global Product and Market Planning at REGENXBIO Inc., where they led the commercialization and licensing of gene therapies for rare neurodegenerative diseases.

Before that, they had their own consulting firm, Noel Dela Paz Consulting, from January 2016 to January 2018, where they served as the Principal.

Noel also has experience working in various roles at different companies. From February to December 2015, they worked as the Director of Global Marketing at BTG plc, leading the commercial planning for pipeline assets and launch planning of VARITHENA®. Noel also worked as a Strategic Marketing Consultant at BTG from August 2014 to February 2015.

From 2011 to 2014, Noel held the position of Global Director of Strategic Marketing at The Janssen Pharmaceutical Companies of Johnson & Johnson, where they were responsible for commercializing pipeline assets in severe asthma, COPD, and other respiratory diseases.

Noel served as a Board Member at Respivert, Ltd., a subsidiary of Janssen Biotech, from 2011 to 2014. Respivert focuses on developing inhaled kinase inhibitors for serious pulmonary conditions.

Noel worked at Teva Pharmaceuticals from 2007 to 2011 in various roles, including Director of Marketing for the ProAir Franchise, Director of New Product Planning and Market Research, and Senior Product Manager for QVAR®.

Noel'scareer began at Altana Pharma in 2003, where they worked as an International Product Manager, leading the launch and commercialization of ALVESCO® in multiple regions.

Overall, Noel Dela Paz has extensive experience in strategic marketing, new product planning, and commercialization in the pharmaceutical industry, with a focus on respiratory diseases and gene therapy.

Noel Dela Paz attended San Beda College, where they pursued a Bachelor of Science degree in Business/Commerce with a major in Accounting. However, the start and end dates of their education were not provided.